Stoke Therapeutics, Inc. (STOK) Capital expenditures 2018–2025
Stoke Therapeutics, Inc. (STOK) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$670,000FY2025 · since FY2018: $935,000 → $670,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $670,000 | +230.0% |
| FY2024 | $203,000 | -87.4% |
| FY2023 | $1.6M | -59.2% |
| FY2022 | $4.0M | +230.2% |
| FY2021 | $1.2M | +14.3% |
| FY2020 | $1.1M | -35.8% |
| FY2019 | $1.6M | +74.9% |
| FY2018 | $935,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice